(Q43856149)

English

Prevalence of the mutational pattern E44D/A and/or V118I in the reverse transcriptase (RT) gene of HIV-1 in relation to treatment with nucleoside analogue RT inhibitors

scientific article published in March 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Prevalence of the mutational pattern E44D/A and/or V118I in the reverse transcriptase (RT) gene of HIV-1 in relation to treatment with nucleoside analogue RT inhibitors (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Brigitte Montes

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Michel Segondy

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 March 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Journal of Medical Virology

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

66

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

299-303

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

1 reference

https://api.crossref.org/works/10.1002%2FJMV.2145

21 January 2018

Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.2145

21 January 2018

Prevalence and conditions of selection of E44D/A and V118I human immunodeficiency virus type 1 reverse transcriptase mutations in clinical practice

1 reference

https://api.crossref.org/works/10.1002%2FJMV.2145

21 January 2018

Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidine

1 reference

https://api.crossref.org/works/10.1002%2FJMV.2145

21 January 2018

Resistance profile of the human immunodeficiency virus type 1 reverse transcriptase inhibitor abacavir (1592U89) after monotherapy and combination therapy. CNA2001 Investigative Group

1 reference

https://api.crossref.org/works/10.1002%2FJMV.2145

21 January 2018

A novel human immunodeficiency virus type 1 reverse transcriptase mutational pattern confers phenotypic lamivudine resistance in the absence of mutation 184V

1 reference

https://api.crossref.org/works/10.1002%2FJMV.2145

21 January 2018

Zidovudine treatment results in the selection of human immunodeficiency virus type 1 variants whose genotypes confer increasing levels of drug resistance.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.2145

21 January 2018

Novel mutation (V75T) in human immunodeficiency virus type 1 reverse transcriptase confers resistance to 2',3'-didehydro-2',3'-dideoxythymidine in cell culture

1 reference

https://api.crossref.org/works/10.1002%2FJMV.2145

21 January 2018

Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)

1 reference

https://api.crossref.org/works/10.1002%2FJMV.2145

21 January 2018

Tipranavir inhibits broadly protease inhibitor-resistant HIV-1 clinical samples

1 reference

https://api.crossref.org/works/10.1002%2FJMV.2145

21 January 2018

Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-infected patients with failure of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.2145

21 January 2018

Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.2145

21 January 2018

Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1002%2FJMV.2145

21 January 2018

Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase

1 reference

https://api.crossref.org/works/10.1002%2FJMV.2145

21 January 2018

Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus didanosine combination therapy. STADI Group

1 reference

https://api.crossref.org/works/10.1002%2FJMV.2145

21 January 2018

Identifiers

10.1002/JMV.2145

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43856149&oldid=2103925804"